87

Table 49. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility 

Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2016

Total 

culture 

positive 

cases

Cases with initial drugsusceptibility testing 

performed1

Resistance2

Isoniazid1 Isoniazid and rifampin1

Reporting area No. (%) No. (%) No. (%)

United States 7,177 6,939 (96.7) 639 (9.2) 97 (1.4)

Alabama 92 91 (98.9) 3 (3.3) 0 (0)

Alaska 45 45 (100.0) 4 (8.9) 0 (0)

Arizona 156 156 (100.0) 21 (13.5) 5 (3.2)

Arkansas 65 64 (98.5) 2 (3.1) 0 (0)

California 1,679 1,633 (97.3) 176 (10.8) 29 (1.8)

Colorado 39 39 (100.0) 3 (7.7) 0 (0)

Connecticut 40 39 (97.5) 2 (5.1) 1 (2.6)

Delaware 15 15 (100.0) 0 (0) 0 (0)

District of Columbia 22 21 (95.5) 2 (9.5) 1 (4.8)

Florida 494 474 (96.0) 45 (9.5) 3 (0.6)

Georgia 219 209 (95.4) 19 (9.1) 3 (1.4)

Hawaii 91 89 (97.8) 10 (11.2) 1 (1.1)

Idaho 13 12 (92.3) 0 (0) 0 (0)

Illinois 256 249 (97.3) 29 (11.6) 3 (1.2)

Indiana 80 80 (100.0) 4 (5.0) 1 (1.3)

Iowa 34 29 (85.3) 4 (13.8) 2 (6.9)

Kansas 35 34 (97.1) 1 (2.9) 0 (0)

Kentucky 62 61 (98.4) 3 (4.9) 0 (0)

Louisiana 109 105 (96.3) 11 (10.5) 0 (0)

Maine 20 20 (100.0) 2 (10.0) 0 (0)

Maryland 164 161 (98.2) 15 (9.3) 2 (1.2)

Massachusetts 131 127 (96.9) 15 (11.8) 3 (2.4)

Michigan 69 69 (100.0) 2 (2.9) 0 (0)

Minnesota 138 136 (98.6) 19 (14.0) 8 (5.9)

Mississippi 49 48 (98.0) 4 (8.3) 2 (4.2)

Missouri 75 71 (94.7) 9 (12.7) 0 (0)

Montana 2 2 (100.0) 0 (0) 0 (0)

Nebraska 20 6 (30.0) 0 (0) 0 (0)

Nevada 41 39 (95.1) 7 (17.9) 0 (0)

New Hampshire 13 13 (100.0) 2 (15.4) 0 (0)

New Jersey 227 211 (93.0) 18 (8.5) 3 (1.4)

New Mexico 34 34 (100.0) 3 (8.8) 0 (0)

New York State3 150 147 (98.0) 11 (7.5) 0 (0)

New York City 452 434 (96.0) 43 (9.9) 10 (2.3)

North Carolina 181 180 (99.4) 10 (5.6) 0 (0)

North Dakota 17 0 (0) 0 — 0 —

Ohio 110 110 (100.0) 6 (5.5) 1 (0.9)

Oklahoma 56 55 (98.2) 2 (3.6) 0 (0)

Oregon 51 51 (100.0) 8 (15.7) 1 (2.0)

Pennsylvania 127 122 (96.1) 11 (9.0) 2 (1.6)

Rhode Island 9 9 (100.0) 1 (11.1) 0 (0)

South Carolina 78 76 (97.4) 4 (5.3) 1 (1.3)

South Dakota 11 11 (100.0) 1 (9.1) 0 (0)

Tennessee 80 77 (96.3) 3 (3.9) 1 (1.3)

Texas 934 914 (97.9) 71 (7.8) 10 (1.1)

Utah 17 17 (100.0) 2 (11.8) 1 (5.9)

Vermont 5 5 (100.0) 0 (0) 0 (0)

Virginia 169 167 (98.8) 12 (7.2) 1 (0.6)

Washington 156 144 (92.3) 15 (10.4) 2 (1.4)

West Virginia 10 8 (80.0) 2 (25.0) 0 (0)

Wisconsin 34 29 (85.3) 2 (6.9) 0 (0)

Wyoming 1 1 (100.0) 0 (0) 0 (0)

American Samoa4 1 0 (0) 0 — 0 —

Fed. States of Micronesia4 33 30 (90.9) 0 (0) 0 (0)

Guam4 43 34 (79.1) 7 (20.6) 2 (5.9)

Marshall Islands4 67 54 (80.6) 1 (1.9) 0 (0)

N. Mariana Islands4 12 8 (66.7) 1 (12.5) 0 (0)

Puerto Rico4 44 41 (93.2) 0 (0) 0 (0)

Republic of Palau4 15 14 (93.3) 0 (0) 0 (0)

U.S. Virgin Islands4 0 0 ... 0 ... 0 ... 1

Patients tested to at least isoniazid and rifampin.

2

Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District 

of Columbia). 

3

Excludes New York City.

4

Not included in U.S. totals. 

Note: Ellipses (...) indicate that the percentage cannot be calculated, and the denominator is 0.